Bioprinting and imaging hub to train the next generation of biomedical engineers at NCCU
Official title: Enhancing Biomedical Engineering, Imaging, and Technology Acceleration (BEITA) at North Carolina Central University
Funded at North Carolina Central University · NIH-11394470 · Data updated 2026-11-12
A grant to build a biotechnology makerspace with bioprinting and imaging tools at North Carolina Central University to train students and researchers over several years.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | North Carolina Central University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project start | September 1, 2025 |
| Project end | August 31, 2028 |
| Funding year | 2026 |
| Award (this year) | $431,000 |
| NIH project number | 5UG3EB037531-02 |
| Project ID | NIH-11394470 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates are students, researchers, and clinicians at NCCU or collaborating institutions who want hands-on experience with bioprinting and biomedical imaging technologies.
✕Less likely to help
Patients may not directly benefit during the grant period if they are not part of related translational efforts or nearby collaboration.
What this research studies
This funding will transform NCCU’s Fab Lab into a Biotechnology Makerspace focused on bioprinting, imaging, and technology acceleration. The UG3 phase will lay the groundwork with an infrastructure framework, management plan, an Advisory Committee, and evaluation methods, while the UH3 phase will expand engagement and measurable improvements. Students and researchers will gain hands-on experience with cutting-edge bioprinting and imaging equipment to accelerate bioscience and biomedical engineering projects. The program aims to strengthen NCCU’s role as a talent hub in biomedical technology at the regional and global levels.
Why it matters
Potential benefit: If successful, patients could benefit from faster development of bioengineering solutions and imaging tools arising from NCCU’s expanded capabilities.
How similar studies have gone: This approach builds on existing Fab Lab activities and bioprinting concepts, with clear expansion plans rather than a novel, untested method.
Where this research is happening
-
North Carolina Central University
Durham, United States Active
Researchers
- Principal investigator: Salazar, Nicole — North Carolina Central University
- Study coordinator: Salazar, Nicole
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.